Oncology / Haematology
Showing 1 - 25 of 2,773
Lung Cancer, Survivorship Trial in Hull (ExerciseGuide Intervention Group)
Completed
- Lung Cancer
- Survivorship
- ExerciseGuide Intervention Group
-
Hull, East Riding Of Yorkshire, United KingdomQueen's Centre for Oncology and Haematology (Castle Hill)
Oct 31, 2022
Onco-haematology Vigilance Card
Recruiting
- Medical Oncology
- +2 more
-
Limoges, FranceCHU de Limoges
Nov 2, 2021
Leukemia, Acute Lymphoblastic Trial in Worldwide (Omitted Doxorubicin, Omitted Vincristine+Dexamethasone pulses, Inotuzumab
Recruiting
- Leukemia, Acute Lymphoblastic
- Omitted Doxorubicin
- +5 more
-
Brussels, Belgium
- +100 more
Dec 12, 2022
Advanced Solid Tumor Trial in Blacktown, Kogarah, Frankston (YH001, Toripalimab)
Completed
- Advanced Solid Tumor
-
Blacktown, New South Wales, Australia
- +2 more
Dec 19, 2022
Breast Cancer, Gastric Cancer, Gastroesophageal-junction Cancer Trial in Australia (IKS014)
Not yet recruiting
- Breast Cancer
- +2 more
-
Concord, New South Wales, Australia
- +4 more
May 30, 2023
Castleman Disease, Castleman's Disease, Giant Lymph Node Hyperplasia Trial in Worldwide
Recruiting
- Castleman Disease
- +8 more
-
Philadelphia, Pennsylvania
- +9 more
Dec 5, 2022
Advanced or Metastatic Solid Tumors Trial in Birtinya, Frankston (KGX101- Cohort 1, KGX101- Cohort 2, KGX101- Cohort 3)
Not yet recruiting
- Advanced or Metastatic Solid Tumors
- KGX101- Cohort 1
- +7 more
-
Birtinya, Queensland, Australia
- +1 more
Oct 3, 2023
Chronic Lymphocytic Leukemia (CLL) Trial in Worldwide (Obinutuzumab, Venetoclax, Fludarabine)
Recruiting
- Chronic Lymphocytic Leukemia (CLL)
- Obinutuzumab
- +5 more
-
Aurora, Colorado
- +55 more
Jan 30, 2023
MDS, Acute Leukemia Trial in Germany (CIK-Cells)
Active, not recruiting
- Myelodysplastic Syndromes
- Acute Leukemia
-
Heidelberg, Baden-Württemberg, Germany
- +4 more
Mar 31, 2022
Renal Cell Carcinoma, Clear Cell, Metastatic Kidney Cancer Trial in Australia (Pembrolizumab plus denosumab)
Recruiting
- Renal Cell Carcinoma, Clear Cell
- Metastatic Kidney Cancer
- Pembrolizumab plus denosumab
-
Albury, New South Wales, Australia
- +15 more
Feb 14, 2022
Advanced/Metastatic Solid Tumors Trial in Frankston, Nedlands, Beijing (EMB07)
Not yet recruiting
- Advanced/Metastatic Solid Tumors
-
Frankston, Victoria, Australia
- +2 more
Nov 3, 2022
NSCLC Trial in Buderim, Adelaide (6-Thio-2'-Deoxyguanosine, Cemiplimab)
Recruiting
- Carcinoma, Non-Small-Cell Lung
-
Buderim, Queensland, Australia
- +1 more
Jul 5, 2022
Tumors Trial in Brisbane, Frankston, Liverpool (ABSK043 oral capsule)
Recruiting
- Neoplasms
- ABSK043 oral capsule
-
Brisbane, Queensland, Australia
- +2 more
Apr 20, 2022
Circulating Tumor Cells (CTC) in Cancer
Recruiting
- Cancer
- Blood samples
- Samples from tumor draining vessels
-
Basel, Switzerland
- +1 more
Nov 8, 2021
B Cell NHL, CLL Trial in Sydney, Melbourne, Mount Pleasant (GB261)
Recruiting
- B Cell NHL
- CLL
- GB261
-
Sydney, New South Wales, Australia
- +4 more
Nov 16, 2022
Tumor Disease - Development and Validation ofPatient Reported
Recruiting
- Cancer
- Patient reported outcome measure
-
Heidelberg, GermanyNational Center for Tumor Diseases, University Hospital Heidelbe
Apr 6, 2022
Advanced Solid Malignancies Trial in Kogarah, Macquarie, Frankston (YH002)
Completed
- Advanced Solid Malignancies
-
Kogarah, New South Wales, Australia
- +2 more
Jul 21, 2022
Acute Myeloid Leukemia (AML) Trial in Worldwide (Selinexor, Hydroxyurea, Ara-C)
Completed
- Acute Myeloid Leukemia (AML)
- Selinexor
- +2 more
-
Los Angeles, California
- +77 more
Jan 24, 2023
NSCLC Trial in Worldwide (biological, drug, radiation)
Recruiting
- Carcinoma, Non-Small-Cell Lung
- pembrolizumab/vibostolimab
- +7 more
-
Hollywood, Florida
- +29 more
Aug 22, 2022
Advanced Solid Tumors, Urothelial Carcinoma, Cholangiocarcinoma Trial in Australia, United States (Drug ICP-192)
Recruiting
- Advanced Solid Tumors
- +2 more
- Drug ICP-192
-
Tucson, Arizona
- +8 more
Jan 28, 2022